{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:35:47Z","timestamp":1761766547623,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ajp.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T20:41:04Z","timestamp":1557348064000},"page":"83-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Clozapine-induced eosinopenia correlates with high drug serum levels: A case report"],"prefix":"10.1016","volume":"43","author":[{"given":"C.","family":"Compagni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Corulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gramaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajp.2019.04.008_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hup.1191","article-title":"Factors affecting interindividual differences in clozapine response: a review and case report","volume":"26","author":"Bersani","year":"2011","journal-title":"Hum. Psychopharmacol."},{"issue":"May (5)","key":"10.1016\/j.ajp.2019.04.008_bib0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2042098618756261","article-title":"Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine","volume":"9","author":"De Berardis","year":"2018","journal-title":"Ther. Adv. Drug Saf."},{"issue":"5","key":"10.1016\/j.ajp.2019.04.008_bib0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.tpj.6500423","article-title":"Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens","volume":"7","author":"Dettling","year":"2007","journal-title":"Pharmacogenom. J."},{"issue":"January","key":"10.1016\/j.ajp.2019.04.008_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajp.2018.12.011","article-title":"A qualitative exploration of clozapine prescribing and monitoring practices in the Arabian Gulfcountries","volume":"39","author":"Ismail","year":"2019","journal-title":"Asian J. Psychiatr."},{"issue":"February","key":"10.1016\/j.ajp.2019.04.008_bib0025","article-title":"Eosinopenia in women with schizophrenia: drug-induced or a sign of gender specific difference in pathogenesis?","volume":"25","author":"Jakobsen","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ajp.2019.04.008_bib0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/asheducation-2015.1.92","article-title":"Eosinophilia: a pragmatic approach to diagnosis and treatment","volume":"2015","author":"Klion","year":"2015","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"March","key":"10.1016\/j.ajp.2019.04.008_bib0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajp.2018.03.008","article-title":"Clozapine use in geriatric patients- Challenges","volume":"33","author":"Mukku","year":"2018","journal-title":"Asian J Psychiatr."},{"issue":"6","key":"10.1016\/j.ajp.2019.04.008_bib0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4088\/JCP.12r08064","article-title":"Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?","volume":"74","author":"Nielsen","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.ajp.2019.04.008_bib0045","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hup.1181","article-title":"Haematological toxicity of clozapine and some other drugs used in psychiatry","volume":"26","author":"Nooijen","year":"2011","journal-title":"Hum. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.ajp.2019.04.008_bib0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF02246112","article-title":"Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study","volume":"117","author":"Olesen","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"issue":"December","key":"10.1016\/j.ajp.2019.04.008_bib0055","article-title":"The eosinophil in infection","volume":"21","author":"Ravin","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.ajp.2019.04.008_bib0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-012-2922-7","article-title":"Clozapine and therapeutic drug monitoring: is there sufficient evidence for an upper threshold?","volume":"225","author":"Remington","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"issue":"October (5)","key":"10.1016\/j.ajp.2019.04.008_bib0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/JCP.0000000000000935","article-title":"Zero eosinophil count as a predictor of clozapine-associated late-onset agranulocytosis: a case report","volume":"38","author":"Yang","year":"2018","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819302126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819302126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:31:53Z","timestamp":1761755513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201819302126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":13,"alternative-id":["S1876201819302126"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2019.04.008","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine-induced eosinopenia correlates with high drug serum levels: A case report","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2019.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}